Angiopoietin-like 4

Angiopoietin-like 4 Molekülinformation

Englischer Name	Angiopoietin-related protein 4	Anzahl der inverkehr gebrachten Arzneimittel	0
Anzahl der klinischen Arzneimittel	3	Target-Alias	Angiopoietin-like protein 4，Hepatic fibrinogen/angiopoietin-related protein，HFARP，ARP4，PGAR，PP1158，PSEC0166，UNQ171/PRO197，Angiopoietin Like 4，Hepatic Fibrinogen/Angiopoietin-Related Protein，Angiopoietin-Related Protein 4，Pp1158，FIAF，NL2，Peroxisome Proliferator-Activated Receptor (PPAR) Gamma Induced Angiopoietin-Related Protein，Hepatic Angiopoietin-Related Protein，PPARG Angiopoietin Related Protein，Fasting-Induced Adipose Factor，Angiopoietin-Like Protein 4，Angiopoietin-Like 4，UNQ171，TGQTL，HARP
Höchste Forschungs- und Entwicklungsphase	Phase 2 Clinical

Englischer Name	Angiopoietin-related protein 4
Target-Alias	Angiopoietin-like protein 4，Hepatic fibrinogen/angiopoietin-related protein，HFARP，ARP4，PGAR，PP1158，PSEC0166，UNQ171/PRO197，Angiopoietin Like 4，Hepatic Fibrinogen/Angiopoietin-Related Protein，Angiopoietin-Related Protein 4，Pp1158，FIAF，NL2，Peroxisome Proliferator-Activated Receptor (PPAR) Gamma Induced Angiopoietin-Related Protein，Hepatic Angiopoietin-Related Protein，PPARG Angiopoietin Related Protein，Fasting-Induced Adipose Factor，Angiopoietin-Like Protein 4，Angiopoietin-Like 4，UNQ171，TGQTL，HARP
Anzahl der inverkehr gebrachten Arzneimittel	0
Anzahl der klinischen Arzneimittel	3
Höchste Forschungs- und Entwicklungsphase	Phase 2 Clinical

Angiopoietin-like 4 Produktliste

Attribut
Protein (1)
Produktbibliothek
Online (1)
Spezies
Human (1)
Etikett
His Tag (1)
Marker
Unconjugated (1)

Produktnummer	Spezies	Expressionssystem	Produktbeschreibung	Proteinstruktur	Reinheit	Eigenschaften	Vorbestellen/Bestellen
AN4-H5243	Human	HEK293	Human Angiopoietin-like 4 / ANGPTL4 (166-406) Protein, His Tag				In den Warenkorb legen

Gesamtmenge1

Angiopoietin-like 4 Molekülhintergrund

Angiopoietin-related protein 4 (ANGPTL4) is also known as Hepatic fibrinogen / angiopoietin - related protein (HFARP), ARP4, PGAR. ANGPTL4 contains one fibrinogen C-terminal domain. ANGPTL4 is a homooligomer , and the homooligomer undergoes proteolytic processing to release its carboxyl fibrinogen-like domain, which circulates as a monomer. The homooligomer unprocessed form is able to interact with the extracellular matrix. ANGPTL4 may act as a regulator of angiogenesis and modulate tumorigenesis. ANGPTL4 inhibits proliferation, migration, and tubule formation of endothelial cells and reduces vascular leakage. ANGPTL4 may exert a protective function on endothelial cells through an endocrine action.

Angiopoietin-like 4 Molekülalias

ANGPTL4,ARP4,FIAF,HFARP,PGAR,pp1158,Angiopoietin like 4

Klinische Arzneimittelinformation

Englischer Name	Forschungscode	Forschungsphase	Firma	Indikationen	Klinische Studie
MAR001	MAR001; MAR-001	Phase 2 Clinical	Mareas Therapeutic Services Inc	Hypertriglyceridemia	Details
Lipisense		Phase 1 Clinical	Lipigon Pharmaceuticals AB, Secarna Pharmaceuticals GmbH & Co KG	Hypertriglyceridemia	Details
A24110He	A24110He; A-24110-He	Phase 1 Clinical	Lipigon Pharmaceuticals AB	Hyperlipidemias; Hypertriglyceridemia	Details